US pharma major AbbVie recently announced top-line results from one of two parallel studies of the pivotal Phase III UP-AA ...

US biotech Iovance Biotherapeutics is cutting 19% of its workforce due to slower-than-expected launch of its ...

Danish biotech Genmab (Nasdaq: GMAB) and US partner AbbVie (NYSE: ABBV) have reported a decisive win in a Phase III study of ...

The cancer immunotherapy market is bracing for its next growth phase as bispecific T-cell engagers gain momentum, according ...

French vaccines developer Valneva announced that the US Food and Drug Administration (FDA) has removed its recommended pause ...

Danish biotech Genmab (Nasdaq: GMAB) posted second-quarter revenue of $925 million, up 19% from a year earlier, driven by ...

UK pharma major GSK (LSE: GSK) today announced that, in connection with the mRNA patent settlement reached between CureVac ...

German family-owned pharma major Boehringer Ingelheim and New York-based Click Therapeutics today announced that the pivotal ...

US artificial intelligence drug discovery firm Chai Discovery has secured $70 million in Series A funding, drawing backing ...

Eli Lilly (NYSE: LLY) posted a 38% jump in revenue to $15.6 billion in the second quarter of 2025, driven by surging demand ...

The Parkinson’s disease (PD) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain, the UK and Japan ...

Swiss generics and biosimilar major Sandoz today presented its financial results for the first half of 2025. and reiterated ...